Edesa Biotech, Inc. - EDSA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jun 18, 2026 | SCHEDULE 13G | Integrated Core Strategies (US) LLC | 5.4% | 520,685 | View |
| Jun 18, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.4% | 520,685 | View |
| Jun 18, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.4% | 520,685 | View |
| Jun 18, 2026 | SCHEDULE 13G | Israel A. Englander | 5.4% | 520,685 | View |
| Jun 16, 2026 | SCHEDULE 13D/A | — | 19.99% | 1,968,160 | View |
| May 15, 2026 | SCHEDULE 13G | Rubric Capital Management LP | 7.74% | 687,500 | View |
| May 15, 2026 | SCHEDULE 13G | David Rosen | 7.74% | 687,500 | View |
| May 15, 2026 | SCHEDULE 13G | Sirenia Capital Management LP | 7.2% | 600,000 | View |
| May 15, 2026 | SCHEDULE 13G | Alex Silverstein | 7.2% | 600,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 0.0% | 2 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 0.0% | 2 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 0.0% | 2 | View |
| May 15, 2026 | SCHEDULE 13G/A | Stonepine Capital Management, LLC | 0.3% | 30,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Stonepine Capital, L.P. | 0.3% | 30,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Stonepine GP, LLC | 0.3% | 30,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Jon M. Plexico | 0.3% | 30,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Daniel Mack | 0.0% | 0 | View |
| Mar 16, 2026 | SCHEDULE 13G | Perceptive Advisors LLC | 6.7% | 563,239 | View |
| Mar 16, 2026 | SCHEDULE 13G | Joseph Edelman | 6.7% | 563,239 | View |
| Mar 16, 2026 | SCHEDULE 13G | Perceptive Life Sciences Master Fund, Ltd. | 6.7% | 563,239 | View |
| Mar 03, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 7.2% | 600,000 | View |
| Mar 03, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 7.2% | 600,000 | View |
| Mar 03, 2026 | SCHEDULE 13G | Steven A. Cohen | 7.2% | 600,000 | View |
| Mar 02, 2026 | SCHEDULE 13D/A | — | 6.8% | — | View |
| Mar 02, 2026 | SCHEDULE 13D/A | — | 19.99% | 1,968,160 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 855,583 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 855,583 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 855,583 | View |
| Feb 18, 2025 | SCHEDULE 13G/A | Thomas A. Satterfield, Jr. | 0.0% | 0 | View |
| Feb 12, 2025 | SCHEDULE 13G/A | Thomas A. Satterfield, Jr. | 6.7% | 232,161 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.